Inhibition of purine metabolism in Ehrlich ascites carcinoma cells by phenanthridinium compounds related to ethidium bromide.
D000225:Adenine; D000818:Animals; D000970:Antineoplastic Agents; D001201:Ascites; D002286:Carcinoma, Ehrlich Tumor; D004996:Ethidium; D005998:Glycine; D009696:Nucleic Acids; D010617:Phenanthridines; D011506:Proteins / Q000378:metabolism*
D000970:Antineoplastic Agents; D009696:Nucleic Acids; D010617:Phenanthridines; D011506:Proteins; C014740:phenanthridinium; D004996:Ethidium; D000225:Adenine; D005998:Glycine
ADENINE; ANTINEOPLASTIC AGENTS; CARCINOMA, EHRLICH TUMOR; GLYCINE; NUCLEIC ACIDS; PROTEIN METABOLISM